Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B6IZ
|
|||
Former ID |
DCL000604
|
|||
Drug Name |
R1678
|
|||
Synonyms |
R-1678; RG-1678
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Phase 3 | [1], [2] | |
Company |
Roche
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H14O4
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)C(=O)C(=O)C3=CC=CC=C3
|
|||
InChI |
1S/C22H14O4/c23-19(15-7-3-1-4-8-15)21(25)17-11-13-18(14-12-17)22(26)20(24)16-9-5-2-6-10-16/h1-14H
|
|||
InChIKey |
FUEGWHHUYNHBNI-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 3363-97-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glycine transporter GlyT-1 (SLC6A9) | Target Info | Blocker | [3] |
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | NRF2 pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7546). | |||
REF 2 | ClinicalTrials.gov (NCT01235559) A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305). U.S. National Institutes of Health. | |||
REF 3 | Clinical pipeline report, company report or official report of Roche (2009). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.